New Immunoassay May Enable Early Kidney Cancer Detection

Share this content:

A new immunoassay that tests for the presence of three biomarkers (nicotinamide N-methyltransferase/NNMT, L-plastin/LCP1, and nonmetastatic cells 1 protein /NM23A) appears to be a valid screening method for the early detection of kidney cancer. John Schieszer has the story in today's Medical Minute.
You must be a registered member of Renal and Urology News to post a comment.

Sign Up for Free e-newsletters